The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and Platelet Mitochondrial Bioenergetics in Patients with Non-Alcoholic Fatty Liver Disease

Hydrogen Therapy for Fatty Liver Disease: A Promising Breakthrough

A recent study found that molecular hydrogen can improve coenzyme Q10 levels and mitochondrial bioenergetics in patients with non-alcoholic fatty liver disease. This breakthrough could lead to a new treatment for fatty liver disease. Molecular hydrogen has also been shown to have other benefits, such as reducing oxidative stress and improving heart health.